Morgan Stanley Maintains Overweight on Arxis, Raises Price Target to $50

Benzinga Newsdesk www.benzinga.com Positive 72.6%

Neg 0% Neu 0% Pos 72.6%

Morgan Stanley analyst Kristine Liwag maintains Arxis (NASDAQ:ARXS) with a Overweight and raises the price target from $44 to $50.